These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25881918)
1. Oxidized HDL and LDL in adolescents with type 2 diabetes compared to normal weight and obese peers. Marin MT; Dasari PS; Tryggestad JB; Aston CE; Teague AM; Short KR J Diabetes Complications; 2015 Jul; 29(5):679-85. PubMed ID: 25881918 [TBL] [Abstract][Full Text] [Related]
2. Effect of obesity and type 2 diabetes, and glucose ingestion on circulating spexin concentration in adolescents. Hodges SK; Teague AM; Dasari PS; Short KR Pediatr Diabetes; 2018 Mar; 19(2):212-216. PubMed ID: 28626942 [TBL] [Abstract][Full Text] [Related]
3. Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents. Freitas MCP; Fernandez DGE; Cohen D; Figueiredo-Neto AM; Maranhão RC; Damasceno NRT Clinics (Sao Paulo); 2018 Oct; 73():e189. PubMed ID: 30365817 [TBL] [Abstract][Full Text] [Related]
4. Circulating oxidized LDL and inflammation in extreme pediatric obesity. Norris AL; Steinberger J; Steffen LM; Metzig AM; Schwarzenberg SJ; Kelly AS Obesity (Silver Spring); 2011 Jul; 19(7):1415-9. PubMed ID: 21331062 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular Risk Factors in Adolescents with Type 1 Diabetes: Prevalence and Gender Differences. Vurallı D; Jalilova L; Alikaşifoğlu A; Özön ZA; Gönç EN; Kandemir N J Clin Res Pediatr Endocrinol; 2024 Mar; 16(1):11-20. PubMed ID: 37559367 [TBL] [Abstract][Full Text] [Related]
6. Advanced oxidative and glycoxidative protein damage markers in the elderly with type 2 diabetes. Gradinaru D; Borsa C; Ionescu C; Margina D J Proteomics; 2013 Oct; 92():313-22. PubMed ID: 23587667 [TBL] [Abstract][Full Text] [Related]
7. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents. Magge SN; Stettler N; Koren D; Levitt Katz LE; Gallagher PR; Mohler ER; Rader DJ J Clin Endocrinol Metab; 2011 May; 96(5):1549-54. PubMed ID: 21367935 [TBL] [Abstract][Full Text] [Related]
8. Serum oxidized low-density lipoprotein levels are related to cardiometabolic risk and decreased after a weight loss treatment in obese children and adolescents. Morell-Azanza L; García-Calzón S; Rendo-Urteaga T; Martin-Calvo N; Chueca M; Martínez JA; Azcona-Sanjulián MC; Marti A Pediatr Diabetes; 2017 Aug; 18(5):392-398. PubMed ID: 27435258 [TBL] [Abstract][Full Text] [Related]
9. Effect of three consecutive meals on the physicochemical properties of HDL and LDL in individuals with the metabolic syndrome and patients with type 2 diabetes. Scheffer PG; Tushuizen ME; Vermue HP; Schindhelm RK; Rustemeijer C; Diamant M Eur J Clin Nutr; 2011 Nov; 65(11):1242-9. PubMed ID: 21712838 [TBL] [Abstract][Full Text] [Related]
10. Oxidized high-density lipoprotein is associated with increased plasma glucose in non-diabetic dyslipidemic subjects. Kotani K; Sakane N; Ueda M; Mashiba S; Hayase Y; Tsuzaki K; Yamada T; Remaley AT Clin Chim Acta; 2012 Dec; 414():125-129. PubMed ID: 22981508 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of oral rosuvastatin intervention on HDL and its associated proteins in men with type 2 diabetes mellitus. Naresh S; Bitla AR; Rao PVLNS; Sachan A; Amancharla YL Endocrine; 2021 Jan; 71(1):76-86. PubMed ID: 32895874 [TBL] [Abstract][Full Text] [Related]
12. Association of Lipoproteins, Insulin Resistance, and Rosuvastatin With Incident Type 2 Diabetes Mellitus : Secondary Analysis of a Randomized Clinical Trial. Dugani SB; Akinkuolie AO; Paynter N; Glynn RJ; Ridker PM; Mora S JAMA Cardiol; 2016 May; 1(2):136-45. PubMed ID: 27347563 [TBL] [Abstract][Full Text] [Related]
13. Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population. Harmon ME; Campen MJ; Miller C; Shuey C; Cajero M; Lucas S; Pacheco B; Erdei E; Ramone S; Nez T; Lewis J PLoS One; 2016; 11(3):e0143102. PubMed ID: 26938991 [TBL] [Abstract][Full Text] [Related]
14. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL). Motamed M; Nargesi AA; Heidari B; Mirmiranpour H; Esteghamati A; Nakhjavani M Clin Lab; 2016 Sep; 62(9):1609-1617. PubMed ID: 28164576 [TBL] [Abstract][Full Text] [Related]
15. Triglyceride glucose index is superior biomarker for predicting type 2 diabetes mellitus in children and adolescents. Yoon JS; Lee HJ; Jeong HR; Shim YS; Kang MJ; Hwang IT Endocr J; 2022 May; 69(5):559-565. PubMed ID: 34924455 [TBL] [Abstract][Full Text] [Related]
16. Association between oxidized LDL, obesity and type 2 diabetes in a population-based cohort, the Health, Aging and Body Composition Study. Njajou OT; Kanaya AM; Holvoet P; Connelly S; Strotmeyer ES; Harris TB; Cummings SR; Hsueh WC; Diabetes Metab Res Rev; 2009 Nov; 25(8):733-9. PubMed ID: 19780064 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein redox status evaluation as a marker of cardiovascular disease risk in patients with inflammatory disease. Ungurianu A; Margină D; Grădinaru D; Băcanu C; Ilie M; Tsitsimpikou C; Tsarouhas K; Spandidos DA; Tsatsakis AM Mol Med Rep; 2017 Jan; 15(1):256-262. PubMed ID: 27909725 [TBL] [Abstract][Full Text] [Related]
18. Relación entre el índice lipoproteínas de baja densidad (LDL)/lipoproteínas de alta densidad (HDL) con enzimas antioxidantes y el índice oxLDL/HDL. Zamora-Ginez I; Baez-Duarte BG; Nieva-Vazquez A; García-Aragón KH; Monjaraz-Guzmán E; Mendoza-Carrera F; Meneses-Zamora P; Flores-Blanco CV; Luna-De Jesús K Gac Med Mex; 2019; 155(5):487-492. PubMed ID: 31695237 [TBL] [Abstract][Full Text] [Related]
19. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus. El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796 [TBL] [Abstract][Full Text] [Related]
20. Impact of exercise training without caloric restriction on inflammation, insulin resistance and visceral fat mass in obese adolescents. Mendelson M; Michallet AS; Monneret D; Perrin C; Estève F; Lombard PR; Faure P; Lévy P; Favre-Juvin A; Pépin JL; Wuyam B; Flore P Pediatr Obes; 2015 Aug; 10(4):311-9. PubMed ID: 25088157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]